Director's Dealing • Dec 16, 2014
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 9307Z
Oxford Biomedica PLC
16 December 2014
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
| 1 | Issuer | Oxford BioMedica PLC |
| 2 | Reason for notification | Notification relates to DTR 3.1.2R |
| 3 | Name of PDMR | Martin Diggle |
| 4 | Connected person | Notification relates to following connected persons: Vulpes Testudo Fund Vulpes Life Sciences Fund |
| 5 | Notification in respect of | Notification in respect of holdings of persons in 4 above |
| 6 | Description of shares | Oxford BioMedica PLC ordinary shares of 1p each |
| 7 | Name of registered shareholders and number of shares | Vulpes Testudo Fund - 85,797,333 shares Vulpes Life Sciences Fund - 447,452,767 shares |
| 8 | Nature of transaction | Disposal |
| 9 | Number of shares acquired | N/A |
| 10 | Percentage of issued class acquired | N/A |
| 11 | Shares disposed | Vulpes Testudo Fund - 85,797,333 shares |
| 12 | Percentage of issued class disposed | Vulpes Testudo Fund - 3.34% |
| 13/14 | Price per share of transactions, and date | Vulpes Testudo Fund 85,797,333 shares @ £0.05 , 12 December 2014 |
| 15 | Total holding following notification and total percentage holding following notification | Vulpes Life Sciences Fund - 447,452,767 shares 17.44% |
| 16 | Date issuer informed | 12 December 2014 |
| 23 | Any additional information | None |
| 24 | Contact name and telephone number | T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBSBDDSXBBGSL
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.